Laurus Labs (BOM:540222) Net Change in Cash : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Laurus Labs's Net Change in Cash for the three months ended in Mar. 2025 was ₹0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Laurus Labs Net Change in Cash Historical Data

The historical data trend for Laurus Labs's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Net Change in Cash Chart

Laurus Labs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Change in Cash

Get a 7-Day Free Trial

467.70

268.90

-296.80

932.70

-394.00

Laurus Labs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-	-

Laurus Labs Net Change in Cash Calculation

Laurus Labs's Net Change in Cash for the fiscal year that ended in Mar. 2025 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	6016.5	+	-6817.2	+	392.8	+	13.9
	=	-394

Laurus Labs's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laurus Labs Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Laurus Labs's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Net Change in Cash

Comparable Companies

BOM:532331 BOM:524494 BOM:532296 BOM:543064 BOM:543635 BOM:506943 NSE:GLAND BOM:532300 BOM:506820 BOM:540596 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines